机器学习和可穿戴传感器用于帕金森病自动诊断辅助:系统性审查
Lazzaro di Biase1,2,3, Pasquale Maria Pecoraro4,5, Giovanni Pecoraro6
1Research Unit of Neurology, Neurophysiology and Neurobiology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128, Rome, Italy. l.dibiase@policlinicocampus.it.
Journal of neurology
|August 14, 2024
概括
机器学习算法与可穿戴传感器相结合,有望改善帕金森病的诊断. 这些技术提供客观的运动性能评估,可能导致更早的检测和更好的临床结果.
科学领域:
- 生物医学工程 生物医学工程
- 神经学 神经学
- 数据科学数据科学数据科学
背景情况:
- 帕金森病的诊断依赖于临床评估,由于缺乏客观生物标志物,临床评估具有显著的错误率.
- 可穿戴传感器和机器学习提供定量,客观的运动性能评估,以提高诊断准确度.
- 本系统性审查探讨了机器学习算法在智能设备中用于帕金森病诊断的使用.
研究的目的:
- 系统地审查有关嵌入智能设备中的机器学习算法的文献,以诊断帕金森病.
- 评估这些技术在提高诊断准确度和实现客观运动性能评估方面的潜力.
主要方法:
- 在PubMed上按照PRISMA指南 (2007年12月 - 2023年7月) 进行了系统的文献搜索.
- 搜索词包括"帕金森病"",诊断"",健康"",控制"",算法"",技术"和"性能".
- 47项研究符合纳入标准,根据作者专业知识增加了另外4项研究.
主要成果:
- 步行分析是机器学习模型评估的最常见的参数.
- 支持矢量机 (SVM) 是使用的最常见的算法.
- 像Random Forest,SVM和K-Nearest Neighbours这样的复杂算法证明了有希望的诊断准确性.
结论:
- 与可穿戴传感器集成的机器学习算法显示了提高帕金森病诊断的潜力.
- 这些工具可以提供客观数据,可能有助于临床医生更早地检测疾病.
- 尽管有希望的结果,但实际应用的挑战和局限性需要解决.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
240
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
240
Parkinson's Disease: Overview
501
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
501


